These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2831128)

  • 21. Clinical applications of corticotropin releasing hormone.
    Daughaday WH
    Mayo Clin Proc; 1990 Jul; 65(7):1026-8. PubMed ID: 2165545
    [No Abstract]   [Full Text] [Related]  

  • 22. Potentiation by vasopressin of corticotropin release induced by corticotropin-releasing factor.
    Yates FE; Russell SM; Dallman MF; Hodge GA; McCann SM; Dhariwal AP
    Endocrinology; 1971 Jan; 88(1):3-15. PubMed ID: 4320769
    [No Abstract]   [Full Text] [Related]  

  • 23. Growth hormone secretagogues as corticotrophin-releasing factors.
    Ghigo E; Arvat E; Camanni F
    Growth Horm IGF Res; 1998 Apr; 8 Suppl B():145-8. PubMed ID: 10990151
    [No Abstract]   [Full Text] [Related]  

  • 24. Corticotropin-releasing factor administered intraventricularly to rhesus monkeys.
    Kalin NH; Shelton SE; Kraemer GW; McKinney WT
    Peptides; 1983; 4(2):217-20. PubMed ID: 6312434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pituitary rsponsiveness to aqueous vasopressin in patients with congenital vasopressin-resistant diabetes insipidus.
    Sober AJ; Gorden P
    J Clin Endocrinol Metab; 1972 Dec; 35(6):924-5. PubMed ID: 4634492
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of lysine vasopressin dimer on corticotropin release in man.
    Takebe K; Kuroshima A; Yamamoto M; Horiuchi Y; Itoh S; Bowers CY; Schally AV
    J Clin Endocrinol Metab; 1968 Jan; 28(1):73-8. PubMed ID: 4294949
    [No Abstract]   [Full Text] [Related]  

  • 27. The clinical implications of corticotropin-releasing hormone.
    Gold PW; Kling MA; Whitfield HJ; Rabin D; Margioris A; Kalogeras K; Demitrack M; Loriaux DL; Chrousos GP
    Adv Exp Med Biol; 1988; 245():507-19. PubMed ID: 2852464
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of corticotrophin therapy on pituitary-adrenal function.
    Carter ME; James VH
    Ann Rheum Dis; 1970 Jan; 29(1):73-80. PubMed ID: 4313509
    [No Abstract]   [Full Text] [Related]  

  • 29. New hypothalamic hormone, corticotropin-releasing factor, specifically stimulates the release of adrenocorticotropic hormone and cortisol in man.
    Grossman A; Kruseman AC; Perry L; Tomlin S; Schally AV; Coy DH; Rees LH; Comaru-Schally AM; Besser GM
    Lancet; 1982 Apr; 1(8278):921-2. PubMed ID: 6122767
    [No Abstract]   [Full Text] [Related]  

  • 30. Investigation of the hypothalamic-pituitary-adrenal axis in mesomorphic types of pig.
    Lister D; Lucke JN; Perry BN
    J Endocrinol; 1972 Jun; 53(3):505-6. PubMed ID: 4339043
    [No Abstract]   [Full Text] [Related]  

  • 31. Site of action of fentanyl in inhibiting the pituitary-adrenal response to surgery in man.
    Hall GM; Lacoumenta S; Hart GR; Burrin JM
    Br J Anaesth; 1990 Aug; 65(2):251-3. PubMed ID: 2223348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACTH response to corticotropin-releasing hormone.
    Fava GA
    Am J Psychiatry; 1987 Aug; 144(8):1102. PubMed ID: 3037927
    [No Abstract]   [Full Text] [Related]  

  • 33. Pituitary-adrenal responses to oCRH and central neuropeptide levels in alcohol amnestic disorder.
    Adinoff B; Martin PR; Eckardt MJ; Bone GH; Gold PW; Linnoila M
    Biol Psychiatry; 1991 Jun; 29(11):1153-5. PubMed ID: 1651774
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of 8-lysine-vasopressin and synthetic analogues of release of ACTH.
    Andersson KE; Arner B; Hedner P; Mulder JL
    Acta Endocrinol (Copenh); 1972 Apr; 69(4):640-8. PubMed ID: 4335823
    [No Abstract]   [Full Text] [Related]  

  • 35. ACTH releasing factor active in the guinea pig.
    SIDEMAN M; SOBEL H
    Proc Soc Exp Biol Med; 1960 Feb; 103():274-7. PubMed ID: 14446415
    [No Abstract]   [Full Text] [Related]  

  • 36. Do narcotics inhibit stress axis responses?
    Gutstein HB
    Anaesthesia; 1995 Jul; 50(7):665. PubMed ID: 7653783
    [No Abstract]   [Full Text] [Related]  

  • 37. Corticotropin releasing factor stimulation test in obsessive compulsive disorder.
    Bailly D; Servant D; Dewailly D; Beuscart R; Racadot A; Fossati P; Parquet PJ
    Biol Psychiatry; 1994 Jan; 35(2):143-6. PubMed ID: 8167212
    [No Abstract]   [Full Text] [Related]  

  • 38. Pituitary-adrenal response to surgical stress in patients receiving corticotrophin treatment.
    Carter ME; James VH
    Lancet; 1970 Feb; 1(7642):328-30. PubMed ID: 4189582
    [No Abstract]   [Full Text] [Related]  

  • 39. Ketoconazole treatment of type 1 autoimmune polyglandular syndrome: effects on pituitary-adrenal axis.
    Feuillan P; Poth M; Reilly W; Bright G; Loriaux DL; Chrousos GP
    J Pediatr; 1986 Aug; 109(2):363-6. PubMed ID: 3016223
    [No Abstract]   [Full Text] [Related]  

  • 40. Some new experiments concerning the "corticotropin releasing factors" and related peptides.
    PRIVAT DE GARILHE M; GROS C
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1963; 245():184-6. PubMed ID: 13986261
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.